Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 421 of 6351
-
Could a simple aspirin pill replace daily shots to prevent postpartum blood clots?
Prevention Recruiting nowThe goal of the PARTUM trial is to determine if taking low-dose aspirin daily for 6 weeks after delivery is similar (non-inferior) to usual care low-molecular-weight heparin injections to prevent venous thromboembolism (VTE: blood clots in the legs or lungs) for postpartum indivi…
Phase 3 • Sponsor: University of Calgary • Aim: Prevention
Last updated Jul 29, 2026 00:00 UTC
-
New hope for hard-to-treat lymphoma: experimental drug combo enters phase 3 trial
Disease control Recruiting nowThe purpose of this study is to evaluate the efficacy and safety of SCTB35 in Combination With Gemcitabine and Oxaliplatin vs Rituximab in Combination With Gemcitabine and Oxaliplatin in Patients With Relapsed or Refractory Diffuse Large B-Cell Lymphoma.
Phase 3 • Sponsor: Sinocelltech Ltd. • Aim: Disease control
Last updated Aug 15, 2026 00:00 UTC
-
New antibiotic YK-1169 takes on deadly hospital pneumonia
Disease control Not yet recruitingTo evaluate the all-cause mortality rate at Day 28 in the YK-1169 group versus the ceftazidime-avibatan injection group in the mITT population.
Phase 3 • Sponsor: Nanjing Yoko Biomedical Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 13:04 UTC
-
New pill targets rare cancer gene in 30-Patient trial
Disease control Recruiting nowThe goal of this clinical trial is to evaluate if lirafugratinib is efficacious and safe to treat adult patients with previously treated, unresectable, locally advanced or metastatic solid tumors (excluding cholangiocarcinoma) harboring FGFR2 fusion or rearrangement. Participant…
Phase 2 • Sponsor: Elevar Therapeutics • Aim: Disease control
Last updated Sep 05, 2026 00:00 UTC
-
New hope for advanced prostate cancer: drug combo trial launches
Disease control Recruiting nowThe purpose of the study is to evaluate the safety, tolerability, pharmacokinetics (PK), pharmacodynamics, and preliminary efficacy of multiple anti-cancer agents in participants with metastatic prostate cancer.
Phase 1/2 • Sponsor: AstraZeneca • Aim: Disease control
Last updated Aug 29, 2026 00:00 UTC
-
Could a simple injection tame stubborn achilles pain?
Disease control Recruiting nowAchilles tendinopathy is a common and often persistent tendon disorder associated with pain, impaired function, and reduced participation in physical activities. Standard care consists of education, load management advice, and progressive calf-strengthening exercises, yet about h…
Phase 3 • Sponsor: Erasmus Medical Center • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
Can a daily supplement shield the brain after delirium?
Disease control Recruiting nowThe aim of this study is to assess whether citicoline (TRAUSAN), a neuroprotective agent involved in membrane phospholipid synthesis and neurotransmission, can prevent or attenuate cognitive decline in older adults who develop perioperative delirium during hospitalization for pro…
Phase 2 • Sponsor: University of Milano Bicocca • Aim: Disease control
Last updated Sep 10, 2026 04:00 UTC
-
Could a heart drug save brains after a burst aneurysm?
Disease control Recruiting nowCerebral vasospasm is a common and serious complication after aneurysmal subarachnoid hemorrhage and is an important cause of delayed cerebral ischemia and poor neurological outcomes. Although standardized medical management is widely used, effective treatment options for cerebra…
Sponsor: Beijing Tiantan Hospital • Aim: Disease control
Last updated Jul 01, 2026 00:00 UTC
-
Can music tame blood sugar and anxiety before surgery?
Symptom relief Recruiting nowPatients with type 2 diabetes mellitus undergoing elective surgery are at increased risk of perioperative hyperglycemia, anxiety, and poor sleep quality because of the physiological and psychological stress associated with surgery. These factors may negatively affect postoperativ…
Sponsor: Istanbul Aydın University • Aim: Symptom relief
Last updated Aug 20, 2026 00:00 UTC
-
New hope for rare brain disease: phase 3 trial of NIO752 underway
Disease control Recruiting nowThis Phase III study is intended to evaluate the efficacy and safety of NIO752 in participants with Progressive Supranuclear Palsy (PSP). Eligible participants will be randomized to receive either NIO752 or placebo followed by an open-label extension.
Phase 3 • Sponsor: Novartis Pharmaceuticals • Aim: Disease control
Last updated Jul 31, 2026 00:00 UTC
-
New hope for hard-to-treat cancers? experimental combo enters phase 2 trial
Disease control Not yet recruitingThis is a Phase 2 study of GV20-0251 in combination with anti-PD-1 monoclonal antibodies (including tislelizumab and toripalimab) for the treatment of participants with unresectable, locally advanced, or metastatic solid tumors who are refractory to, intolerant of, or ineligible …
Phase 2 • Sponsor: GV20 Therapeutics • Aim: Disease control
Last updated Jun 27, 2026 13:04 UTC
-
New strategy: removing tumors one by one after chemo for stomach and pancreatic cancers
Disease control Recruiting nowThis is a randomized, open label, single-center, phase 2, randomized controlled trial of sequential cytoreductive intervention versus standard of care therapy for patients with intervenable oligometastatic (stage IV) cancer of the upper gastrointestinal (GI) tract and undetectabl…
Phase 2 • Sponsor: Yale University • Aim: Disease control
Last updated Sep 10, 2026 00:00 UTC
-
Gene therapy shot aims to tame wet AMD in both eyes
Disease control Recruiting nowThe purpose of this study is to evaluate safety, effectiveness and durability of a gene therapy called Ixo-vec (Ixoberogene soroparvovec) when administered to the contralateral (second) eye of adult participants (≥ 50 years of age) who have been diagnosed with bilateral neovascul…
Phase 2 • Sponsor: Adverum Biotechnologies, Inc. • Aim: Disease control
Last updated Aug 07, 2026 00:00 UTC
-
Could a nasal spray after childbirth ward off postpartum depression?
Disease control Not yet recruitingEsketamine has rapid-onset antidepressant effects and may reduce postpartum depression in parturients with prenatal depressive symptoms. However, its adverse neuropsychiatric symptoms limits clinical application. Dexmedetomidine can alleviate these adverse symptoms and has indepe…
Phase 4 • Sponsor: Peking University First Hospital • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
New hope for aggressive lymphoma: triple-drug combo enters human trials
Disease control Not yet recruitingSingle-Arm Clinical Study of Zeprumetostat in Combination with Glofitamab + GemOx in Patients with Relapsed/ Refractory DLBCL
Phase 1/2 • Sponsor: The First Affiliated Hospital with Nanjing Medical University • Aim: Disease control
Last updated Jun 27, 2026 13:06 UTC
-
Brain pacemaker could tame tough OCD
Disease control Recruiting nowThe goal of this clinical trial is to learn if deep brain stimulation (DBS) works to treat refractory obsessive-compulsive disorder (OCD). The main questions it aims to answer are: * Assess the effects of the anteromedial sub-thalamic nucleus (amSTN)stimulation on obsessive/comp…
Sponsor: Nader Pouratian • Aim: Disease control
Last updated Jun 27, 2026 12:28 UTC
-
Light-Based therapy may tame kidney transplant rejection
Disease control Recruiting nowThis study aims to describe, over a one-year period, the clinical, biological, and histological evolution of a cohort of kidney transplant recipients who developed antibody-mediated rejection and were treated with extracorporeal photopheresis.
Sponsor: Centre Hospitalier Universitaire de Besancon • Aim: Disease control
Last updated Jul 01, 2026 00:00 UTC
-
Triple threat: new combo therapy targets Hard-to-Treat stomach cancer
Disease control Not yet recruitingThis study is a domestic, multicenter, single-arm clinical trial designed to evaluate the efficacy and safety of heterogeneous radiotherapy (high and low dose) sequenced with iparomlimab and tuvonralimab plus SOX as a first-line treatment for unresectable locally advanced or meta…
Phase 4 • Sponsor: Huazhong University of Science and Technology • Aim: Disease control
Last updated Jun 27, 2026 12:01 UTC
-
New hope for advanced bladder cancer: maintenance drug aims to keep tumors in check
Disease control Not yet recruitingThis study represents an innovative opportunity in the treatment of metastatic urothelial carcinoma
Phase 2 • Sponsor: Gruppo Oncologico Italiano di Ricerca Clinica • Aim: Disease control
Last updated Jun 27, 2026 11:00 UTC
-
AI-Powered screening aims to catch lung cancer early in veterans
Prevention Recruiting nowLung cancer is responsible for more deaths in the United States than breast, prostate and colon cancer combined and is the number one cancer killer of Veterans. This is because lung cancer is usually diagnosed when the disease has spread, and cure is less likely. Lung cancer scre…
Sponsor: VA Office of Research and Development • Aim: Prevention
Last updated Jun 28, 2026 00:00 UTC